Euro RSCG Life shops are rebranded as Havas Life

Share this article:
Donna Murphy
Donna Murphy

The Euro RSCG Life agencies are switching to the name Havas Life, as one of Havas's biggest networks undergoes a rebranding, the holding company said Monday.

The move was part of a larger change in which Havas, aiming for a simpler corporate structure and a unified culture, renamed the Euro RSCG Worldwide network and its agencies as Havas Worldwide. The rebrand will not create any changes in leadership, the group said.

“Today with the rebranding we're making a small change, but it's one we want to use as a catalyst for driving big change through Havas and the broader industry,” said David Jones, global CEO of Havas, in a statement.

Donna Murphy, global CEO, partner, Havas Health, called the rebranding of Euro RSCG Life “a natural step in streamlining the Havas Health structure,” adding that for clients, the new name “more clearly demonstrates our unified offering and shared culture.”

The change goes into effect today at 60 Euro RSCG Life agencies in 50 countries. For instance, in North America, Euro RSCG Life's oldest shop—Euro RSCG Life LM&P NY & Chicago—becomes Havas Life Metro NY & Chicago. Euro RSCG Life MetaMax, which does a lot of global work, becomes Havas Life New York. Euro RSCG Life Medicom becomes Havas Life Medicom, while Havas Drive becomes Havas Life Digital.

Havas also said that the Havas Health networks, including Havas Life and Health4Brands (H4B), will now be housed within Havas Creative, along with the Havas Worldwide network, the Arnold Worldwide micro-network and all other communications agencies. The Havas group's other main brand will be Havas Media, which includes all its global media agencies.

The Havas Health renaming follows a rebrand in June by Interpublic Group's McCann Healthcare Worldwide, under which McCann agencies, including several in the US, took on the McCann name to more closely align with their parent.

“For any message to stick with today's customers, they need a singular, consistent brand experience,” added Murphy.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...